Company Overview and News

 
California utility proposes wildfire safety measures

2018-09-10 nzherald.co.nz
A California utility is vowing to replace 3,400 miles of overhead power lines with insulated wire to reduce the risk of them sparking when hit by tree limbs or other objects.
SCEDN SCEDP SCE

 
California approves measure to pass on wildfire costs

2018-09-01 nzherald.co.nz
SACRAMENTO, Calif. (AP) — The California Legislature voted Friday to allow power companies to raise electric bills to cover the cost of lawsuits from last year's deadly wildfires amid fears that Pacific Gas & Electric Co., would otherwise face financial ruin.
SCEDN SCEDP SCE

4
Strong Investment Plan Aids Edison International's Growth

2018-08-27 zacks
We recently updated research report on Edison International (EIX - Free Report) , the parent holding company of Southern California Edison (SCE) primarily engaged in the business of supplying electricity to southern California. The company enjoys a strong portfolio of regulated utility assets and well-managed merchant energy operations, which present a lower risk profile than its utility-only peers.
EIX SCEDN SCEDP DTJ AQN SCE AEE DTW DTV MED ACHC DTY

 
Edison International (EIX) Down 0.9% Since Last Earnings Report: Can It Rebound?

2018-08-27 zacks
A month has gone by since the last earnings report for Edison International (EIX - Free Report) . Shares have lost about 0.9% in that time frame, underperforming the S&P 500.
EIX SCEDN SCEDP SCE

2
Fixed-To-Floating Preferred Arbitrage: Edison International

2018-08-10 seekingalpha - 2
Instead of trying to determine the right direction, we found a way to participate utilizing arbitrage.
EIX SCEDN SCEDP SCE

9
As Economics Improve, Solar Shines in Rural America - IEEE Spectrum

2018-07-29 spectrum.ieee.org - 2
A five-year effort by electric cooperatives to expand the use of solar energy in rural parts of the United States is coming to a successful conclusion.
SOJA SO DUKH SCEDN SCEDP DUK SCE FSLR

5
Edison International (EIX) Beats on Q2 Earnings, Lags Sales

2018-07-27 zacks
Edison International (EIX - Free Report) reported second-quarter 2018 earnings per share (EPS) of 84 cents from continuing operations, beating the Zacks Consensus Estimate of 82 cents by 2.4%. The bottom line declined by a penny from the year-ago quarter’s tally. Total Revenues Edison International's second-quarter 2018 revenues were $2,815 million, missing the Zacks Consensus Estimate of $2,955 million by 4.
EIX SCEDN EA SCEDP SCE AEP NVR TRN NEE

 
California Wildfires Were Terrible Last Year. Will This Year Be Worse? - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
EIX SCEDN SCEDP SRE SCE

 
Business News Roundup, July 13

2018-07-12 sfgate
If Pacific Gas and Electric Co. decides to switch off power lines in your neighborhood to prevent a wildfire, the company has to notify you first. If that’s at all possible.
SCEDN SCEDP SCE

 
California slashes emissions, hits major greenhouse gas goal years early - SFChronicle.com

2018-07-12 sfchronicle
In a major win for California’s fight against global warming, the state appears to have hit its first target for cutting greenhouse gases — and it reached the goal early.
SCEDN SCEDP SCE

20
Edison (EIX) to Expand Charge Ready, Seeks CPUC's Approval

2018-06-27 zacks
Edison International’s (EIX - Free Report) unit, Southern California Edison (“SCE”), appealed to the California Public Utilities Commission ("CPUC") for the expansion of Charge Ready 2. It is a program that will expand the installation of electric vehicle (“EV”) charging infrastructure in California. This $760-million, four-year program will allow the company to install 48,000 charging ports. Recently, SCE installed the 1000th EV charging point to increase the availability of in transportation.
EIX AEE SCEDN SCEDP OTTR AGR SCE

 
Edison Wants to Spend $760 Million on EV Charging in California - Bloomberg

2018-06-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
EIX SCEDN SCEDP SCE

2
Why PG&E Isn't Getting Much California Love

2018-06-02 seekingalpha - 1
A bill backed by PG&E that would require utility ratepayers to absorb fire-related liability costs in some cases is running into opposition.
EIX PCG SCEDN SCEDP SRE SCE

 
California’s biggest-ever wildfire declared extinguished

2018-06-01 newsinfo.inquirer.net
GOLETA, Calif. — Officials declared the largest wildfire in recorded California history officially extinguished Friday, nearly six months after it ignited and later burned hillsides that washed away in deadly mudslides northwest of Los Angeles.
SCEDN SCEDP SCE

20
Why is Edison International (EIX) Down 4.9% Since its Last Earnings Report?

2018-05-31 zacks
A month has gone by since the last earnings report for Edison International (EIX - Free Report) . Shares have lost about 4.9% in that time frame.
EIX SCEDN SCEDP STX SCE SU ALIMR IMMR SU

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 842400756